CMMBVSNIVF• 3 Months (Normalized)
CMMB vs NIVF (Chemomab Therapeutics Ltd. vs NewGenIvf Group Limited)
Showing Closing Date Range from Jul 1 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
CMMB Performance $1.67
-1.76%
Chemomab Therapeutics Ltd.
Normalized Baseline0.00%
NIVF Performance $0.59
+%
NewGenIvf Group Limited
Normalized Baseline0.00%
Alpha Spread Margin NIVF LEADS
-1.76 pts
NIVF outperforming by 1.76 percentage points
CMMBNIVF
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
CMMB NIVF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(63 dates)
| Date | CMMB Price | CMMB Gain (%) | NIVF Price | NIVF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $1.67 | -1.76% | $- | - | |
| Sep 28, 2026 | $1.64 | -3.53% | $- | - | |
| Sep 25, 2026 | $2.16 | +27.06% | $- | - | |
| Sep 24, 2026 | $2.20 | +29.41% | $- | - | |
| Sep 23, 2026 | $2.28 | +34.12% | $0.59 | -88.10% | +122.22% |
| Sep 22, 2026 | $2.51 | +47.65% | $0.73 | -85.21% | +132.86% |
| Sep 21, 2026 | $2.48 | +45.88% | $0.72 | -85.48% | +131.36% |
| Sep 18, 2026 | $2.61 | +53.53% | $0.72 | -85.50% | +139.03% |
| Sep 17, 2026 | $2.80 | +64.71% | $0.72 | -85.58% | +150.29% |
| Sep 16, 2026 | $2.65 | +55.88% | $0.79 | -84.17% | +140.05% |
| Sep 15, 2026 | $2.47 | +45.29% | $0.84 | -83.06% | +128.35% |
| Sep 14, 2026 | $2.45 | +44.12% | $0.93 | -81.27% | +125.39% |
| Sep 11, 2026 | $2.58 | +51.76% | $1.06 | -78.62% | +130.38% |
| Sep 10, 2026 | $2.60 | +52.94% | $1.11 | -77.62% | +130.56% |
| Sep 09, 2026 | $2.69 | +58.24% | $1.10 | -77.82% | +136.06% |
Page 1 of 5